Fresh from presenting multiple studies at the 2026 Digestive Disease Week (DDW) and ENDO Conferences, Dr. Pimentel is ready to share new insights on IBS and SIBO research, testing advances, and treatment approaches β and then answer YOUR questions live.
This is your rare opportunity to hear directly from the world's leading researcher on SIBO & IBS and get answers to persistent gut health concerns.
π Sign up now to join Dr. Mark Pimentel on Wednesday, June 24th at 7pm ET (4pm PT) for this LIVE Q&A session.
Join us live for a chance to win a special gift at the end of the webinar!
Dr. Mark Pimentel is a renowned gastroenterologist and researcher, serving as the Executive Director of the Medically Associated Science and Technology (MAST) program at Cedars-Sinai. He is widely recognized for his pioneering work on IBS and SIBO, having published over 150 scientific papers and authored two books on the subjects.
Dr. Pimentel's research has led to significant advancements in understanding the relationship between gut microbiome and gastrointestinal disorders, resulting in the development of new diagnostic tests and treatment approaches for IBS and SIBO.
*By submitting your email, you agree to receive periodic emails from Gemelli Biotech about webinars, product info, gut health education, and offers tailored to your needs. You can unsubscribe at any time.
Trio-Smart is the only clinical breath test that measures the levels of hydrogen, methane, and hydrogen sulfide to provide you with a more complete picture of gut health.
IBS-Smart is the only licensed, patented antibody blood test for the diagnosis of IBS.
Trio-Smart and IBS-Smart are brought to you by Gemelli Biotech. Learn more about our work, principles, and leadership at gemellibiotech.com.
Β© 2026 Gemelli Biotech. All Rights Reserved.